[go: up one dir, main page]

DK0668272T3 - Fremgangsmåde til fremstilling af tetrazolylforbindelser - Google Patents

Fremgangsmåde til fremstilling af tetrazolylforbindelser

Info

Publication number
DK0668272T3
DK0668272T3 DK95101055T DK95101055T DK0668272T3 DK 0668272 T3 DK0668272 T3 DK 0668272T3 DK 95101055 T DK95101055 T DK 95101055T DK 95101055 T DK95101055 T DK 95101055T DK 0668272 T3 DK0668272 T3 DK 0668272T3
Authority
DK
Denmark
Prior art keywords
preparation
tetrazolyl compound
tetrazolyl compounds
tetrazolyl
protected
Prior art date
Application number
DK95101055T
Other languages
English (en)
Inventor
Yasushi Shida
Kokichi Yoshida
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DK0668272T3 publication Critical patent/DK0668272T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95101055T 1994-01-28 1995-01-26 Fremgangsmåde til fremstilling af tetrazolylforbindelser DK0668272T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP823394 1994-01-28

Publications (1)

Publication Number Publication Date
DK0668272T3 true DK0668272T3 (da) 2000-09-18

Family

ID=11687442

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95101055T DK0668272T3 (da) 1994-01-28 1995-01-26 Fremgangsmåde til fremstilling af tetrazolylforbindelser

Country Status (9)

Country Link
US (2) US5578733A (da)
EP (1) EP0668272B1 (da)
AT (1) ATE194603T1 (da)
CA (1) CA2141175C (da)
DE (1) DE69517832T2 (da)
DK (1) DK0668272T3 (da)
ES (1) ES2147798T3 (da)
GR (1) GR3034464T3 (da)
PT (1) PT668272E (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043709A1 (fr) 2000-12-01 2002-06-06 Takeda Chemical Industries, Ltd. Procede de production d'une preparation contenant une substance bioactive
EP1444988A4 (en) 2001-11-13 2007-04-25 Takeda Pharmaceutical CANCER AGENT
WO2003074008A2 (en) * 2002-03-01 2003-09-12 Merck & Co., Inc. Aminoalkylphosphonates and related compounds as edg receptor agonists
EP1511739B1 (en) * 2003-03-17 2008-04-30 Teva Pharmaceutical Industries Ltd. Polymorphs of valsartan
AU2003230193A1 (en) * 2003-03-27 2004-10-18 Hetero Drugs Limited Novel crystalline forms of candesartan cilexetil
WO2004094391A2 (en) 2003-04-21 2004-11-04 Teva Pharmaceutical Industries Ltd. Process for the preparation of valsartan and intermediates thereof
CZ297016B6 (cs) * 2003-08-27 2006-08-16 Zentiva, A.S. Zpusob odstranování trifenylmethanové chránicí skupiny z 1-trityl-5-(4'-subst. aminomethyl-1,1' -bifenyl-2-yl)-1H-tetrazolu a zpusob výroby draselné soli losartanu, irbesartanu a valsartanu s jeho pouzitím
CA2542499A1 (en) * 2003-10-16 2005-04-28 Teva Pharmaceutical Industries Ltd. Preparation of candesartan cilexetil
WO2005051928A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Process for production of tetrazolyl compounds
EP1713795A2 (en) * 2004-02-11 2006-10-25 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
MXPA06012702A (es) * 2004-05-05 2007-04-02 Teva Pharma Preparacion de candesartan cilexetil de alta pureza.
WO2005123720A1 (en) * 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited Fine particles of the angiotensin ii antagonist candesartan cilexetil and process for production thereof
EP1655298A1 (en) * 2004-11-03 2006-05-10 LEK Pharmaceuticals d.d. Novel polymorph forms of candesartan cilexetil
EP1812423A1 (en) * 2004-11-11 2007-08-01 LEK Pharmaceuticals D.D. Process for the synthesis of tetrazoles
CA2590894A1 (en) * 2005-01-14 2006-07-20 Teva Pharmaceutical Industries Ltd. Preparation of crude candesartan cilexetil
US20070082055A1 (en) * 2005-05-10 2007-04-12 Ziv Kurgan Stable micronized candesartan cilexetil and methods for preparing thereof
EP1896455A2 (en) 2005-06-06 2008-03-12 Medichem, S.A. Process for the preparation of tetrazolyl compounds
EP1816131A1 (en) * 2006-02-06 2007-08-08 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of olmesartan medoxomil
WO2007017135A2 (en) * 2005-07-29 2007-02-15 Krka Process for the preparation of olmesartan medoxomil
SI22127A (sl) 2005-10-07 2007-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo kandesartan cileksetila
CZ299265B6 (cs) * 2005-10-20 2008-05-28 Zentiva, A. S. Zpusob výroby 1-(cyklohexyloxykarbonyloxy)ethyl-2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)bifenyl-4-yl]methyl]benzimidazol-7-karboxylátu (candesartan cilexetilu)
ITTO20060560A1 (it) * 2006-07-27 2008-01-28 S I M S S R L Composti intermedi per la preparazione di antagonisti dell¿angiotensina ii
WO2008012371A1 (en) * 2006-07-28 2008-01-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography
EP2170868A1 (en) * 2007-07-11 2010-04-07 Alembic Limited An improved process for the preparation of candesartan cilexetil
MX2011012460A (es) 2009-05-20 2012-04-20 Ranbaxy Lab Ltd Proceso para la preparacion de olmesartan medoxomil.
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof
KR101251741B1 (ko) 2010-12-16 2013-04-05 동화약품주식회사 칸데사르탄실렉세틸의 개선된 제조방법
CN103396408A (zh) * 2013-08-13 2013-11-20 河南华商药业有限公司 坎地沙坦酯中杂质b的制备方法
CN109851612A (zh) * 2019-01-30 2019-06-07 浙江省食品药品检验研究院 一种坎地沙坦酯晶体及其制备方法
CN109776503A (zh) * 2019-01-30 2019-05-21 浙江省食品药品检验研究院 一种坎地沙坦酯晶体及其制备方法
CN109627234A (zh) * 2019-01-30 2019-04-16 浙江省食品药品检验研究院 一种坎地沙坦酯晶体及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
GB9017480D0 (en) * 1990-08-09 1990-09-26 Ici Plc Chemical process
TW209213B (da) * 1991-08-21 1993-07-11 Yamanouchi Pharma Co Ltd
IL103020A (en) * 1991-09-10 1998-10-30 Tanabe Seiyaku Co 3-(1,1'-Biphenyl-4-yl-methyl)-4,5,6,7-tetrahydro-3h-imidazo Ú4,5-c¾ pyridine-4-carboxylic acids their preparation and pharmaceutical compositions containing them
DE4132632A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Substituierte imidazolyl-propensaeurederivate
EP0550313A1 (fr) * 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
DE4212748A1 (de) * 1992-04-16 1993-10-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
EP0668272A3 (en) 1995-08-30
CA2141175C (en) 2006-12-12
DE69517832T2 (de) 2000-11-09
EP0668272B1 (en) 2000-07-12
US5578733A (en) 1996-11-26
EP0668272A2 (en) 1995-08-23
GR3034464T3 (en) 2000-12-29
ES2147798T3 (es) 2000-10-01
CA2141175A1 (en) 1995-07-29
US5763619A (en) 1998-06-09
PT668272E (pt) 2000-10-31
ATE194603T1 (de) 2000-07-15
DE69517832D1 (de) 2000-08-17

Similar Documents

Publication Publication Date Title
DK0668272T3 (da) Fremgangsmåde til fremstilling af tetrazolylforbindelser
DK0508307T3 (da) Optisk aktive sekundære aminforbindelser, fremgangsmåde til fremstilling af en optisk aktiv sekundær aminforbindelse og fremgangsmåde til fremstilling af en optisk aktiv carboxylsyre ved anvendelse af denne forbindelse
CA2109482A1 (en) Process for producing alanylglutamine
EP0936214A3 (en) Method for producing isocyanatoalkyl (meth)acrylate
BR9400018A (pt) Processo para a preparação de um composto, composto e sua aplicação
DK90786A (da) Fremgangsmaade til fremstilling af stearyl-beta-(3,5-dibutyl-4-hydroxyphenyl)propionat og bis-(beta-(3,5-dibutyl-4-hydroxybenzyl)-methylcarboxyethyl)sulfid
FR2703682B1 (fr) Procédé de préparation de (méth)acrylate(s) d'alkylimidazolidone.
DK1097130T3 (da) Fremgangsmåde til fremstilling af hydroxymethylthiosmörsyre
MXPA04000382A (es) Proceso para preparacion de l-ribavirina.
IE830166L (en) Process for preparing an azetidinone derivative
ITMI921318A1 (it) Processo per la preparazione di perfluoropoliossialchileni funzionalizzati
WO1999033788A3 (de) Verfahren zur herstellung von aromatischen brommethylbiphenyl-verbindungen
EA200100894A1 (ru) Новый способ получения алендроновой кислоты
IN184319B (da)
PT798297E (pt) "processo para a producao de 2-alcoxi-6-(trifluorometil)-pirimidin-4-ol"
MX9404783A (es) Procedimiento para la preparacion de erdosteina.
IL126554A (en) γ - OXO - HOMOPHENYLALANINE DERIVATIVES AND PROCESS FOR PRODUCING HOMOPHENYLALANINE DERIVATIVES BY REDUCING THE SAME
ES2106756T3 (es) Procedimiento para la preparacion de nepinalona.
ES2098611T3 (es) Procedimiento para la fabricacion de endo/exo-8-n,n-dialquilaminoexotriciclo(5.2.1.0 2,6)decano.
ATE244228T1 (de) Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate
DK0834574T3 (da) Fremgangsmåde til oprensning af K-252a
AU3759697A (en) Process for amines
EP1229029A4 (en) METHOD FOR PRODUCING A BENZYLAMINE CONNECTION
MD970270A (en) Process for obtaining the acid chloride compounds
FI851073L (fi) Inhibitor foer dopamin- -hydroxylas.